GENMAB A/S (GMAB) Form 6-K — Jun 17, 2026

Genmab A/S filed a Form 6-K disclosing the grant of employee warrants as of June 11, 2026, under the authorizations provided by the General Meeting. The Board of Directors issued 15,494 warrants to employees, granting the right to subscribe for ordinary shares at an exercise price of DKK 1,616.50 per share. The warrants are subject to a three-year vesting cliff, after which they may be exercised until the seventh anniversary of the issue date. The scheme includes standard provisions for acceleration upon a change of control and specific vesting outcomes based on employment termination status, such as Good Leaver or Bad Leaver classifications.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.